Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment

Bictegravir, an investigational integrase inhibitor from Gilead Sciences, was highly potent, well tolerated and worked as well as dolutegravir (Tivcay) in a phase 2 clinical trial, according to

Published
14 February 2017
By
Liz Highleyman
Cake, candles and a wish for more HIV cures

An HIV workshop pays tribute to Timothy Ray Brown, whose cure 10 years ago fueled research — and hope

Published
14 February 2017
From
Fred Hutch
US: Should People With HIV Stock Up on Meds in Fear of Health Care Cuts?

As the Trump admimistration and Congress discuss sweeping changes to health care, should people with HIV start squirreling away their meds in case they lose access? HIV advocates say don't panic -- you'll likely be fine. But there are still things you can think about and steps you can take.

Published
13 February 2017
From
The Body
Across western Europe, migrants from all parts of the world start HIV treatment later

An analysis of over 150,000 people living with HIV in eleven western European countries shows that people born abroad are more likely to start HIV treatment with

Published
13 February 2017
By
Roger Pebody
In the search for an HIV cure, David Evans explains “freedom” and how to better involve women & people of color

David Evans, director of research advocacy at Project Inform, talks about an ambitious HIV cure social science research project that will investigate some of the ethical and moral dilemmas cropping up in HIV cure research.

Published
09 February 2017
From
BETA blog
'Keeping the Foot on the Gas' of HIV Research at CROI 2017

When controversies arise, researchers return to the science. So at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017, which will convene next week amid funding concerns and boycotts, researchers will be diving deep into the evidence.

Published
08 February 2017
From
Medscape (requires free registration)
Case Report of PrEP Failure: What Can We Learn From It?

The New England Journal of Medicine has published the first well-documented case of HIV pre-exposure prophylaxis (PrEP) failure despite good medication adherence. We heard lots of this information at CROI last year, and again I'm impressed at the extraordinary degree of virologic investigation done on a case from clinical practice.

Published
08 February 2017
From
The Body Pro
Women significantly more likely than men to have suboptimal adherence to HIV therapy

Women are more likely than men to have poor adherence to combination antiretroviral therapy (cART), according to Canadian research published in HIV Medicine. Adherence was monitored in

Published
08 February 2017
By
Michael Carter
Nigeria: Nigeria Aids Agency Warns Against HIV Cure 'Publicity'

The Director General of the National Agency for the Control of AIDS, Sani Aliyu, has expressed displeasure with the publicity given to the claim of a cure for HIV/AIDS by a Nigerian professor.

Published
07 February 2017
From
AllAfrica
Fake news claims that Walmart bananas have HIV virus are fruitless

"HIV virus detected in Walmart bananas after 10 year old boy contracts the virus," reads the headline on a post we first saw on Feb. 6, 2017, from a website called CNNews3.com. Facebook users flagged the story as part of the social media platform’s efforts to stamp out fabricated news stories.

Published
07 February 2017
From
Politifact

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.